Home / Science and Tech / Path Breaking New Cancer 'Vaccine' Cured 97% of Tumors in Mice. What Does That Mean for People?

Path Breaking New Cancer 'Vaccine' Cured 97% of Tumors in Mice. What Does That Mean for People?

By Andrew Alpin, 27 June 2018

Advertisement

13The new treatment is different from engineered immune cells

In comparison to CAR T cell therapy, the new treatment looks more promising as it will not need doctors or lab professionals to remove immune cells to fight cancer. Doctor Ronald Levy, professor of oncology at Stanford University School of Medicine said "We're attacking specific targets without having to identify exactly what proteins the T cells are recognizing,” Incidentally the professor is the senior author of the Science Translational Medicine study.

The new treatment is different from engineered immune cells

Image Source: nbcbayarea.com

14A huge milestone in the war against cancer

Experts feel that the new medicine is extremely interesting as it will apply to colon and breast cancer which currently does not have a treatment involving immunotherapy. If the trials are successful, it will be a huge milestone in the war against cancer. Doctor Police feels that even though there may be a long way to go, we have gone further down the road.

A huge milestone in the war against cancer

Image Source: alarabiya.net

15The new vaccine in phase 1

Advertisement

The new cancer vaccine is now in phase 1 of a clinical study where the safety of the treatment will be tested. Once that is successful, it will go on to test if the treatment itself is effective and safe or not. But researchers are extremely optimistic and hopeful.

The new vaccine in phase 1

Image Source: stanford.edu

16Who is eligible for the trials?

According to the website of Stanford Institute, only patients with non-Hodgkin’s lymphoma are eligible for the human trials phase 1. Moreover, for those who do not qualify there are other clinical trials going on at Stanford that one can volunteer for.

Who is eligible for the trials?

Image Source: express.co.uk

Advertisement

Page 4of 4